Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Profire Energy | PFIE | Oct 31, 2024 | 2.50 | 0.00 |
Profound Medical | PROF | Oct 31, 2024 | 7.27 | -2.42 |
ProFrac A | ACDC | Oct 31, 2024 | 5.96 | -2.85 |
PROG | PRG | Oct 31, 2024 | 43.67 | -0.57 |
Progress Software | PRGS | Oct 31, 2024 | 64.09 | -0.91 |
Progressive | PGR | Oct 31, 2024 | 242.83 | -0.07 |
Progyny | PGNY | Oct 31, 2024 | 15.05 | -2.15 |
ProKidney | PROK | Oct 31, 2024 | 1.60 | -4.76 |
Prologis | PLD | Oct 31, 2024 | 112.94 | -2.53 |
ProMIS Neurosciences | PMN | Oct 31, 2024 | 1.27 | +16.51 |
PropertyGuru | PGRU | Oct 31, 2024 | 6.63 | 0.00 |
ProPetro | PUMP | Oct 31, 2024 | 6.91 | -4.16 |
ProPhase Labs | PRPH | Oct 31, 2024 | 2.29 | +0.88 |
ProQR Therapeutics | PRQR | Oct 31, 2024 | 3.50 | -4.37 |
PROS | PRO | Oct 31, 2024 | 19.80 | -5.04 |
ProShares Bitcoin Strategy ETF | BITO | Oct 31, 2024 | 19.88 | -2.83 |
Proshares Ultra FTSE Europe | UPV | Oct 31, 2024 | 61.10 | -1.56 |
ProShares UltraShort Bloomberg Natural Gas | KOLD | Oct 31, 2024 | 80.80 | +7.22 |
Proshares Ultrashort FTSE Europe | EPV | Oct 31, 2024 | 7.59 | +1.40 |
Prospect Capital | PSEC | Oct 31, 2024 | 5.19 | +0.58 |
Prospect Capital A Pref | PSEC-A | Oct 31, 2024 | 19.50 | +0.52 |
Prosperity Bancshares | PB | Oct 31, 2024 | 73.20 | -1.36 |
Protagenic Therapeutics | PTIX | Oct 31, 2024 | 0.66 | -0.02 |
Protagonist Therapeutics | PTGX | Oct 31, 2024 | 45.84 | -3.74 |
Protalix Bio Therapeutics | PLX | Oct 31, 2024 | 1.17 | 0.00 |
Protara Therapeutics | TARA | Oct 31, 2024 | 2.51 | +7.27 |
Prothena | PRTA | Oct 31, 2024 | 17.00 | -5.97 |
Proto Labs | PRLB | Oct 31, 2024 | 27.40 | -0.72 |
Provident Bancorp | PVBC | Oct 31, 2024 | 10.37 | -2.08 |
Provident Financial | PROV | Oct 31, 2024 | 15.57 | -1.80 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.